SURGERY PARTNERS INC
NASDAQ: SGRY (Surgery Partners, Inc.)
Last update: 2 hours ago14.48
-0.37 (-2.49%)
| Previous Close | 14.85 |
| Open | 14.80 |
| Volume | 1,073,207 |
| Avg. Volume (3M) | 1,911,567 |
| Market Cap | 1,872,868,864 |
| Price / Earnings (Forward) | 18.05 |
| Price / Sales | 0.590 |
| Price / Book | 1.14 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2025 |
| Profit Margin | -6.09% |
| Operating Margin (TTM) | 11.55% |
| Diluted EPS (TTM) | -1.53 |
| Quarterly Revenue Growth (YOY) | 8.20% |
| Total Debt/Equity (MRQ) | 108.05% |
| Current Ratio (MRQ) | 1.89 |
| Operating Cash Flow (TTM) | 265.40 M |
| Levered Free Cash Flow (TTM) | 142.56 M |
| Return on Assets (TTM) | 3.97% |
| Return on Equity (TTM) | -0.35% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Surgery Partners, Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 1.88 |
|
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 1.51% |
| % Held by Institutions | 111.91% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Bain Capital Investors Llc | 30 Sep 2025 | 49,946,972 |
| Janus Henderson Group Plc | 30 Sep 2025 | 13,036,583 |
| Pentwater Capital Management Lp | 30 Sep 2025 | 11,681,000 |
| King Street Capital Management, L.P. | 30 Sep 2025 | 9,339,930 |
| Clearbridge Investments, Llc | 30 Sep 2025 | 4,242,620 |
| Glenview Capital Management, Llc | 30 Sep 2025 | 2,546,735 |
| Norges Bank | 30 Jun 2025 | 1,196,983 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 31.00 (RBC Capital, 114.09%) | Buy |
| Median | 24.50 (69.20%) | |
| Low | 18.00 (Barclays, 24.31%) | Hold |
| Average | 24.50 (69.20%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 15.79 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Mizuho | 18 Dec 2025 | 19.00 (31.22%) | Buy | 15.83 |
| 17 Nov 2025 | 22.00 (51.93%) | Buy | 15.06 | |
| JP Morgan | 24 Nov 2025 | 20.00 (38.12%) | Hold | 16.29 |
| Barclays | 21 Nov 2025 | 18.00 (24.31%) | Hold | 15.84 |
| UBS | 13 Nov 2025 | 29.00 (100.28%) | Buy | 15.31 |
| Benchmark | 11 Nov 2025 | 30.00 (107.18%) | Buy | 15.75 |
| RBC Capital | 11 Nov 2025 | 31.00 (114.09%) | Buy | 15.75 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 11 Dec 2025 | Announcement | Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering |
| 11 Dec 2025 | Announcement | Surgery Partners, Inc. Announces Add-On Senior Notes Offering |
| 08 Dec 2025 | Announcement | Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care |
| 10 Nov 2025 | Announcement | Surgery Partners, Inc. Announces Third Quarter 2025 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |